SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 13, 2001
ENZON, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-12957 22-2372868
(State or other jurisdiction of (Commission (IRS Employer
incorporation) File Number) Identification)
20 Kingsbridge Road, Piscataway, New Jersey 08854
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (732) 980-4500
NA
(Former name or former address, if changed since last report
Item 5. Other Events
Enzon, Inc. announced today it intends, subject to market and other
conditions, to make a private offering of $400 million of Convertible
Subordinated Notes due 2008 with an option to issue an additional $60 million of
notes.
At the option of the holder, the notes will be convertible into shares of
Enzon's Common Stock under certain circumstances at a price to be determined and
will be subordinated in right of payment to all senior indebtedness of Enzon.
Enzon intends to use the proceeds of the sale for general corporate
purposes, including our internal discovery and development programs and the
development of new technologies, general working capital and possible future
acquisitions.
The securities being offered have not been registered under the Securities
Act of 1933, as amended, or applicable state securities laws, and unless so
registered, may not be offered or sold in the United States, except pursuant to
an applicable exemption from the registration requirements of the Securities Act
of 1933, as amended, and applicable state securities laws.
This shall not constitute an offer to sell or the solicitation of an offer
to buy any of these securities. This is being issued pursuant to and in
accordance with Rule 135c under the Securities Act of 1933, as amended.
Except for the historical information herein, the matters discussed in this
Form 8-k include forward-looking statements that may involve a number of risks
and uncertainties. Actual results may vary significantly based upon a number of
factors which are described in the Company's Form 10-K, Form 10-K/A, Form 10-Qs
and Form 8-Ks on file with the SEC, including without limitation, risks in
obtaining and maintaining regulatory approval for indications and expanded
indications, market acceptance of and continuing demand for Enzon's products and
the impact of competitive products and pricing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: June 14, 2001
ENZON, INC.
-----------------------------
(Registrant)
By: /s/ KENNETH J. ZUERBLIS
-----------------------------
Kenneth J. Zuerblis
Vice President, Finance and
Chief Financial Officer